PMID

Data

Article Title

Organization

Dual leucine zipper kinase inhibitors: potential treatments for neurodegenerative diseases.

Therachem Research Medilab (India)

Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.

Califia Bio

Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.

Sichuan University

AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).

Ambit Biosciences

Deciphering the multifunctional role of dual leucine zipper kinase (DLK) and its therapeutic potential in disease.

Southwest Jiaotong University

Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration.

Genentech

MIXED LINEAGE KINASE INHIBITORS AND METHODS OF USE

Department of Health And Human Services

SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOF

The Johns Hopkins University